Trial intelligence / Profile preview

Pilot Study of Vesnarinone in AIDS-Related Kaposi's Sarcoma

NCT00002131Phase 2Completed

Sponsor
Otsuka America Pharmaceutical
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Vesnarinone in Kaposi sarcoma (KS), sponsored by Otsuka America Pharmaceutical. Status: completed.

02

Drugs

Vesnarinone
03

Conditions

Kaposi sarcoma (KS)

Beyond the preview

Go deeper on NCT00002131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call